Increased apoptosis during papilloma development in mice susceptible to tumor progression

Molecular Carcinogenesis

Volumn 20, Issue 1, 1997, Pages 137-142

  Stern, Mariana C ^a   Durán, Hebe A ^a,b   McKenna, Emma A E ^a   Conti, Claudio J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b LABORATORIO TANDAR   (Argentina)

Author keywords

p53; Papilloma; SENCAR mice; Squamous cell carcinoma; Susceptibility

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CHEMICAL CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MOUSE; MUTAGENIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR PROMOTION;

ANIMALS; APOPTOSIS; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; HYPERPLASIA; MICE; MICE, INBRED SENCAR; PAPILLOMA; SKIN; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0030830335     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199709)20:1<137::AID-MC15>3.0.CO;2-2     Document Type: Conference Paper

References (45)

1. Williams GT. Programmed cell death: Apoptosis and oncogenesis. Cell 65:1097-1098, 1991.
2. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257, 1972.
3. Cohen JJ. Apoptosis. Immunol. Today 14:126-130, 1993.
4. Du MQ, Pan LX, Singh N, Isaacson PG. Differential apoptosis between low and high grade lymphomas of mucosa-associated lymphoid tissues (Meeting Abstract). J Pathol 173(Suppl):172A, 1994.
5. El-Labban NG, Osorio-Herrera E. Apoptotic bodies and abnormal dividing epithelial cells in squamous cell carcinoma. Histopathology 10:921-931, 1986.
6. Kiberu S, Pringle JH, Lauder I. A comparative study of indices of cell proliferation, apoptosis and bcl-2 expression in low grade and high grade non Hodgkin's lymphoma (Meeting Abstract). J Pathol 175(Suppl.):154A, 1995.
7. Kuwashima Y, Uehara T, Kurosumi M, Shiromizu K, Matsuzawa M, Kishi K. Cell dynamics of undifferentiated carcinomas of the ovary. Immunohistochemical estimation of their growth fraction and apoptotic status. Eur J Oncol 16:268-273, 1995.
8. Tatebe S, Ishida M, Kasagi N, Tsujitani S, Kaibara N, Ito H. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: Analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling. Int J Cancer 65:173-177, 1996.
9. Shoji Y, Saegusa M, Takano Y, Ohbu M, Okayasu I. Correlation of apoptosis with tumor cell differentiation, progression, and HPV infection in cervical carcinomas. J Clin Pathol 49:134-138, 1996.
10. Ishida M, Gomyo Y, Tatebe S, Ohfuji S, Ito H. Apoptosis in human gastric mucosa, chronic gastritis, dysplasia and carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Virchows Arch 428:229-235, 1996.
11. Gaffney EF. The extent of apoptosis in different types of high grade prostatic carcinoma. Histopathology 25:269-273, 1994.
12. Frankfurt OS, Robb JA, Sugarbaker EV, Villa L. Apoptosis in human breast and gastrointestinal carcinomas. Detection in histological sections with monoclonal antibody to single-stranded DNA. Anticancer Res 16:1979-1988, 1996.
13. Hino N, Higashi T, Nouso K, Nakatsukasa H, Tsuji T. Apoptosis and proliferation of human hepatocellular carcinoma. Liver 16:123-129, 1996.
14. Saegusa M, Takano Y, Wakabayashi T, Okayasu I. Apoptosis in gastric carcinomas and its association with cell proliferation and differentiation. Jpn J Cancer Res 86:743-748, 1995.
15. Iwasaki K, Izawa M, Mihara M. UV-induced apoptosis in rat skin. J Dermatol Sci 12:31-35, 1996.
16. Kane KS, Maytin EV. Ultraviolet B-induced apoptosis of keratinocytes in murine skin is reduced by mild local hyperthermia. J Invest Dermatol 104:62-67, 1995.
17. Li G, Mitchell DL, Ho VC, Reed JC, Tron VA. Decreased DNA repair but normal apoptosis in ultraviolet-irradiated skin of p53-transgenic mice. Am J Pathol 148:113-1123, 1996.
18. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature 372:773-776, 1994.
19. Fischer SM, O'Connell JF, Conti CJ, et al. Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters. Carcinogenesis 8:421-424, 1987.
20. Gimenez-Conti IB, Bianchi AB, Fischer SM, Reiners JJ, Conti CJ, Slaga TJ. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice. Cancer Res 52:3432-3435, 1992.
21. Stern MC, Gimenez-Conti IB, Conti CJ. Genetic susceptibility to papilloma progression in the SENCAR mice. Carcinogenesis 16:1947-1953, 1995.
22. Zar JH. Biostatistical Analysis. Prentice Hall, New Jersey, 1984.
23. Oltvai ZN, Milliman CL, Rorsmeyer S. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619, 1993.
24. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of an in vivo distribution of bax, a dominant inhibitor of bcl-2. Am J Pathol 145:1323-1336, 1994.
25. Morales-Dcret CRJ, Van de Rijn M, Le Brun DP, Smoller BR. bcl-2 expression in primary malignancies of the skin. Arch Dermatol 131:909-912, 1995.
26. Verhaegh MFJM, Sanders CJG, Arends JW, Neumann HAM. Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer. Br J Dermatol 132:740-744, 1995.
27. McCall CA, Cohen JJ. Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonucleases. J Invest Dermatol 97:111-114, 1991.
28. Norris DA. Differential control of cell death in the skin. Arch Dermatol 131:945-948, 1995.
29. Tamada Y, Takama H, Kitamura T, et al. Identification of programmed cell death in normal human skin tissues by using labelling of fragmented DNA. Br J Dermatol 131:521-524, 1994.
30. Haake AR, Polawoska RR. Cell death by apoptosis in epidermal biology. J Invest Dermatol 101:107-112, 1993.
31. Bauer G. Resistance to TGF-β-induced elimination of transformed cells is required during tumor progression. Int J Oncol 6:1227-1229, 1995.
32. Game SM, Huelsen A, Patel V, et al. Progressive abrogation of TGF-β1 and EGF growth control is associated with tumor progression in ras-transfected human keratinocytes. Int J Cancer 52:461-470, 1996.
33. Yonis-Rouach E, Resnitsky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347, 1991.
34. Ramqvist T, Magnusson KP, Wang Y, Szekely L, Klein G, Wiman KG. Wild type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53 gene. Oncogene 8:1495-1500, 1993.
35. Ryan JJ, Danish R, Gottlieb CA, Clarke MA. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol Cell Biol 13:711-719, 1993.
36. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 89:4495-4499, 1992.
37. Ruggeri B, Caamano J, Goodrow T, et al. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res 51:6615-6621, 1991.
38. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075-3079, 1991.
39. Sager R. Genetic instability, suppression and human cancer. Cancer Surv 3:321-334, 1984.
40. deWind N, Dekker M, Berns A, Radman M, Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance hyperrecombination and predisposition to cancer. Cell 82:321-330, 1995.
41. Sands AT, Sanchez A, Conti CJ, Bradley A. Mice deficient for XPC are highly susceptible to UV-induced carcinogenesis. Nature 377:162-165, 1995.
42. Ionov Y, Peninado M, Malkhos S, Shibata D, Perucho M. Ubiquitous somatic mutation in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-561, 1993.
43. Madrich P. Mismatch repair genetic stability and cancer. Science 266:1959-1960, 1994.
44. Parsons R, Li GM, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75:1227-1236, 1993.
45. Friedberg EC, Walker GC, Siede W. DNA Repair and Mutagenesis. ASM Press, Washington D.C., 1995.